Netrias, LLC, doing business as Netrias, has been awarded a $3.1 million firm fixed price definitive contract by the National Institutes of Health, an agency of the Department of Health and Human Services, to deliver PATHENGINE II, a platform to automate the integration of data to predict pathogenic potential. The research will be conducted under the Small Business Technology Transfer program, Phase II. Performance will take place in Annapolis, Maryland over a period of four years concluding in November 2024. The award is designated as a total small business set aside. No subcontractors or additional context were provided.
Generated 12/25/23, 4:17 AM